Tomas Jandik Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Tomas Jandik's research investigates the application of cardiac resynchronization therapy (CRT) in patients with dilated cardiomyopathy and heart failure. His work includes the design and rationale for the CRT-REALITY study, which examines the efficacy of CRT-D or CRT-P in patients without specific high-risk markers on cardiac magnetic resonance imaging. Jandik also explores the impact of social connections and network centrality on financial outcomes, such as CEO insider trading gains, capital structure in supplier-customer relationships, and merger performance. His publications span both medical research and business/economics fields. Jandik holds a h-index of 15 with 1,683 total citations across 52 publications. He has collaborated with Dobrina Georgieva Jandik on four shared publications.
Metrics
- h-index: 15
- Publications: 52
- Citations: 1,714
Selected Publications
-
Social Connections and Capital Allocation in Multidivisional Firms (2025)
-
Does social network connectedness affect acquirer merger performance around the world? (2025)
-
Personal connections, financial advisors and M&A outcomes (2024)
-
CTO Network Centrality and Corporate Innovation (2024)
-
Social connections and innovation in diversified conglomerates (2024)
-
Network centrality, connections, and social capital: Evidence from CEO insider trading gains (2021)
Collaboration Network
Top Collaborators
- Network centrality, connections, and social capital: Evidence from CEO insider trading gains
- Personal connections, financial advisors and M&A outcomes
- Does social network connectedness affect acquirer merger performance around the world?
- Does Social Network Connectedness Affect Acquirer Merger Performance Around the World?
- The effect of social connections on capital structure in supplier-customer relationships
- Social Connections and Capital Allocation in Multidivisional Firms
- Social Connections and Innovation in Diversified Conglomerates
- Social connections and innovation in diversified conglomerates
- Does social network connectedness affect acquirer merger performance around the world?
- Does Social Network Connectedness Affect Acquirer Merger Performance Around the World?
- Network centrality, connections, and social capital: Evidence from CEO insider trading gains
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale
- Cardiac Resynchronization and Defibrillator Therapy (CRT-D) or CRT Alone (CRT-P) in patients with dilated cardiomyopathy and heart failure without late gadolinium enhancement (LGE) cardiac magnetic resonance imaging (CMRI) high-risk markers - CRT-REALITY study - Study design and rationale